By Natasha Roberts
Date: Thursday 02 Feb 2012
Mining firm Noventa says that operations have suffered from a "plague" of beetles as a result of tropical storms which have hit the firm's Marropino site in Mozambique over the past 10 days. The Rove Beetle is very poisonous and around 30% of the workforce at Marropino have been affected by the severe skin and eye irritations caused by coming into contact with the insects. The firm was keen to emphasise that an effective treatment has now been administered and a pesticide is being sprayed to erradicate the infestation. Progress at Marropino has been delayed and is set to start in March, a delay of around a month. Shares dropped 2.78% to 17.5p.
| Colt boss buys on weakness | 22-Jul-2011 | ShareCast |
| Amphion takes bath on sale of Myconostica stake | 24-May-2011 | ShareCast |
| Amphion revenues hit by IP programme shake-up | 28-Feb-2011 | ShareCast |
| Small caps round-up: Costain, Nostra Terra Oil, ... | 05-Jan-2011 | ShareCast |
| Asia Citrus director makes juicy share sale | 18-Oct-2010 | ShareCast |
| Funding update | 09-May-2012 | 09:20 | RNS |
| Partner Company Update | 01-May-2012 | 07:00 | RNS-R |
| Partner Company Update | 28-Mar-2012 | 07:00 | RNS |
| Director Dealings | 28-Feb-2012 | 07:00 | RNS |
| Funding Update | 23-Feb-2012 | 16:36 | RNS |
| NAB buys Aviva’s Australia business | 22-Jun-2009 | The Independent |
No recent information was found.
No recent information was found.
Amphion’s ... |
20-Aug-2009 | Proactive Investors |
Company builder Amphion Innovations PLC expec... |
19-Jan-2009 | Proactive Investors |
| Currency | UK Pounds |
| Share Price | 4.13p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 6.88 |
| 52 Week Low | 2.25 |
| Volume | 0 |
| Shares Issued | 135.01m |
| Market Cap | £5.57m |
| Beta | 0.37 |
| RiskGrade | 174 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
| CEO | Richard C E Morgan |
| CFO | Robert Joseph Bertoldi |
You are here: research